Dariya Nikitin
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness.
Journal: NPJ vaccines
Published: November 25, 2025
Further Evidence and Analysis are Required to Determine the Level of Protection Against Gonorrhea Provided by 4CMenB.
Journal: The Journal of infectious diseases
Published: March 22, 2025
New Insights into Gonorrhea Natural History and Protection by 4CMenB, and a Call for More Analyses of Existing Studies and Enhanced Data Collection.
Journal: Open forum infectious diseases
Published: December 21, 2024
The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial.
Journal: The Lancet. Infectious diseases
Published: July 08, 2024
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis.
Journal: The Lancet. Global health
Published: March 23, 2024
Ebola virus disease mathematical models and epidemiological parameters: a systematic review.
Journal: The Lancet. Infectious diseases
Published: March 19, 2024
Cost-effectiveness of 4CMenB Vaccination Against Gonorrhea: Importance of Dosing Schedule, Vaccine Sentiment, Targeting Strategy, and Duration of Protection.
Journal: The Journal of infectious diseases
Published: October 01, 2023
Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review.
Journal: The Lancet. Infectious diseases
Published: July 05, 2023
We need estimates of gonorrhoea vaccine protection and symptomaticity by sex and anatomical site.
Journal: The Lancet. Infectious diseases
Published: May 03, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026